Holo’s €1 Million Boost: Personalised Lab Testing and Health Tracking for All

Barcelona-based startup Holo recently announced the closing of a €1 million pre-Seed funding round aimed at revolutionizing how individuals approach and manage their health. The company’s all-in-one app combines advanced lab testing, AI technology, and functional medicine, alongside integration with popular devices such as Apple Watch, Garmin, and Oura.

The funding round was led by Calm/Storm Ventures and Mission VC, with additional participation from ENISA, as well as a group of notable business angels and early customers. Among the investors are prominent figures in the tech industry including Javier López, Emilio Nicolás, Carlos Villanueva, Álex Rodríguez, Álvaro López, Samuel Fernández, Sergi Molins, José de Cabo, Esteve Almirall, and Luis Sanz.

CEO and co-founder Francesc Navarro emphasized the importance of empowering individuals to take control of their well-being proactively, rather than waiting for health issues to arise. He likened Holo’s mission to creating the “Revolut of health.”

The European startup scene in preventive health, diagnostics, and longevity has been gaining momentum, with various companies securing new funding rounds in similar verticals. Aeon in Switzerland, Blue Longevity Clinic in Bulgaria, Epigenica in Sweden, Skleo Health in Germany, and MELP in Lithuania are among the notable recipients of recent funding.

Holo’s pre-Seed round aligns with the broader trend of European startups focusing on preventive health and consumer-oriented platforms. While Holo is in the early stages compared to some of its counterparts, its presence in Barcelona adds geographical diversity to the sector, as none of the comparable companies mentioned are based in Spain.

Emilio Rodríguez, co-founder and Chief Product Officer, highlighted the potential for individuals to have complete health profiles accessible on their smartphones in the near future. This information can not only prevent diseases but also improve daily quality of life.

Founded in 2024 by Francesc Navarro, Emilio Rodríguez, and Sergio Mosquera, Holo aims to shift the focus of healthcare from hospitals to everyday life. The platform offers comprehensive lab tests, wearables integration, and personalized medical reports reviewed by prevention and longevity specialists.

Sergio Mosquera, CTO, and co-founder, emphasized the transformative potential of combining science, technology, and user experience in improving health outcomes. Holo’s goal is to set a new standard in prevention and well-being.

With the recent pre-Seed funding, Holo plans to expand its presence in Spain and prepare for European expansion in 2026. The funds will be allocated towards product development, medical integrations, and clinical collaborations across Europe.

The company already collaborates closely with Laboratorios Echevarne in Spain and is developing new services and personalized longevity programs. Holo aims to establish itself as the leading platform for preventive health in Europe.

Calm/Storm Ventures General Partner Lucanus Polagnoli commended the Holo team’s expertise and execution capabilities, gained from their experience at Factorial, a leading European tech unicorn. He highlighted the potential for Holo to address the growing demand for preventive health and longevity solutions in Europe.

In conclusion, Holo’s innovative approach to health management and proactive well-being aligns with the evolving landscape of preventive healthcare in Europe. With a strong focus on technology integration, personalized medicine, and user experience, Holo is poised to make a significant impact in the industry.